Obligate Progression Precedes Lung Adenocarcinoma Dissemination CANCER DISCOVERY Caswell, D. R., Chuang, C., Yang, D., Chiou, S., Cheemalavagu, S., Kim-Kiselak, C., Connolly, A., Winslow, M. M. 2014; 4 (7): 781-789

Abstract

Despite its clinical importance, very little is known about the natural history and molecular underpinnings of lung cancer dissemination and metastasis. Here we employed a genetically-engineered mouse model of metastatic lung adenocarcinoma in which cancer cells are fluorescently marked to determine whether dissemination is an inherent ability or a major acquired phenotype during lung adenocarcinoma metastasis. We find very little evidence for dissemination from oncogenic Kras-driven hyperplasias or most adenocarcinomas. p53 loss is insufficient to drive dissemination but rather enables rare cancer cells in a small fraction of primary adenocarcinomas to gain alterations that drive dissemination. Molecular characterization of disseminated tumors cells indicates that down-regulation of the transcription factor Nkx2-1 precedes dissemination. Finally, we show that metastatic primary tumors possess a highly proliferative sub-population of cells with characteristics matching those of disseminating cells. We propose that dissemination is a major hurdle during the natural course of lung adenocarcinoma metastasis.

View details for DOI 10.1158/2159-8290.CD-13-0862

View details for Web of Science ID 000338708900024